Oncology News

Liver transplant recipients with hepatocellular carcinoma experienced significantly reduced disease recurrence when their exposure to calcineurin inhibitors was limited during initial immunosuppressive therapy in a recent study.

WASHINGTON — With liver disease now the leading cause of death among patients coinfected with HIV and hepatitis C, treatment of the HCV coinfection should be a key part of the care of HIV-infected patients, a speaker said here.

WASHINGTON — The increase in the number of hepatocellular carcinoma patients in the United States being wait-listed for transplant is leading to a greater incidence of wait-listing for all individuals with hepatitis C, a speaker said here.

WASHINGTON — Heightened levels of serum gamma-glutamyl transferase in noncirrhotic hepatitis C patients who had achieved sustained virologic response signals a significantly greater risk for hepatocellular carcinoma, a speaker said here.

Healio.com will present live coverage of the American Association for the Study of Liver Diseases’ annual Liver Meeting running through Tuesday in Washington.

SAN DIEGO — Patients with diabetes- and steatohepatitis-related liver disease are more likely to develop hepatocellular carcinoma, cirrhosis and encephalopathy — and at a faster rate — than nondiabetic patients, a presenter said here.

Patients treated for hepatocellular carcinoma with 90Y radioembolization had better health-related quality of life than transarterial chemoembolization recipients, despite presenting with more advanced disease in a recent study.

Laser ablation was comparably effective to radiofrequency ablation in inducing complete necrosis of small hepatocellular carcinoma in a study presented at the International Liver Cancer Association Annual Conference in Washington, DC.

Laser ablation was comparably effective to radiofrequency ablation in inducing complete necrosis of small hepatocellular carcinoma in a study presented at the International Liver Cancer Association Annual Conference in Washington, DC.

Patients with hepatocellular carcinoma who experienced early response to treatment had significantly longer overall survival and time to extrahepatic metastasis development in a study presented at the International Liver Cancer Association Annual Conference in Washington, DC.